LFSTNasdaqServices-Health ServicesFiscal year ends December 31
LifeStance Health Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$11.77+0.03 (+0.26%)
Close on Oct 19, 2026
- Market cap
- $4.56B
- P/E (TTM)
- 90.5
- Dividend yield
- –
LifeStance Health Group, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- 4.9%
- Net margin
- 3.2%
- Return on equity, FY2025
- 0.7%
Financial strength
- Current ratio
- 1.38
- Debt to equity
- 0.19
- Debt to assets
- 12.5%
- Cash to current liabilities
- 82.2%
Valuation
- P/E ratio
- 90.5
- Price to sales
- 2.88
- Price to book
- 3.09
- Dividend yield
- –